Course Description:

Cutaneous T-cell lymphoma (CTCL) rarely follows a fixed treatment algorithm. Two patients with the same stage may need very different care depending on whether the skin, the blood, the lymph nodes, or a transformed clone is driving the disease. Therapy aimed at the wrong compartment exposes patients to toxicity without controlling the problem that matters; therapy matched to the dominant problem can produce durable control while preserving future options.

This interactive, case-based dinner program shows how the Moffitt multidisciplinary team thinks through CTCL compartment by compartment. Faculty from dermatology, radiation oncology, hematology/oncology, hematopathology, and advanced practice will review how each compartment is defined, how that assessment guides the choice among skin-directed therapy, radiation therapy, and systemic therapy, and how the plan should change when the dominant problem changes.